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Long-term cytolytic T-lymphocyte (CTL) lines that are specific for distinct antigens associated with different
phases of the replicative cycle of the murine cytomegalovirus (MCMV) w'ere established by cloning ofCTL lines
derived from lymph nodes of latently infected BALB/c mice. Two CTL clones were characterized in detail. Both
displayed the Lyt-2+, L3T4- surface phenotype, and the recognition of their respective target antigens was
class I (DLd) major histocompatibility complex antigen restricted. Clone Slwas specific for a structural antigen
of MCMV, and clone IE1 detected an MCMV-specified immediate-early (IM) membrane antigen. Clone IEl
retained lytic activity, antigen specificity, and self-restriction after prolonged propagation in the presence of
recombinant human interleukin-2 without restimulation by antigen. This interleukin-2-dependent line of the
clone IEl, line IEl-IL, can serve as a reference line for the definition of the antigenic determinant TEl of an
IE membrane antigen.
The immediate-early (IE, a) genes of herpesviruses are the
first viral genes transcribed by host cell RNA polymerase
after infection of permissive cells (3, 8, 11, 25). The IE
proteins perform a central regulatory role in the replication
of herpesviruses. As exemplified for indicator genes, such as
the E2 adenovirus early gene (9) and the human ,-globin
gene (6), herpesvirus IE proteins can activate other tran-
scription units, and an IE protein (IE-Vmwl75) of herpes
simplex virus type 1 is required throughout the replicative
cycle to promote the transition from IE to early (,) gene
expression and the transcription of late (y) genes (26).
Selective synthesis of murine cytomegalovirus (MCMV)
IE proteins (12, 21) leads to the expression of at least one IE
membrane antigen (21). A marked number of cytolytic T
lymphocytes (CTL) activated during acute infection of mice
(20) specifically lyse IE-infected indicator cells (22), and IE
membrane antigen-specific memory CTL reside in lymphatic
tissues during viral latency (21), suggesting that in the
natural host the expression of IE genes is implicated in
immune surveillance.
At present it has not been established whether only one or
more IE membrane antigens exist, and molecules that carry
lymphocyte-detected IE determinants have not yet been
characterized biochemically. An 89-kilodalton phosphopro-
tein (pp89) located mainly in the nucleus and cytoplasm of
the infected cell is the predominant MCMV IE protein (12).
This protein in its authentic form or in a processed form and
also additional IE polypeptides of low abundance (12) come
into question as antigens. The identification of a particular
IE membrane antigen requires a monospecific probe.
In this paper we describe the selection and characteriza-
tion of the first cloned long-term CTL line specific for an IE
membrane antigen of a herpesvirus. This line is compared
with another cloned long-term CTL line specific for a struc-
tural (S) antigen of the same virus.
We have observed previously that BALB/c (H-2d
haplotype) mice, infected intraperitoneally as newborns with
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102 PFU of mouse embryo fibroblast (MEF)-adapted MCMV
(ATCC VR-194, Smith strain), harbor memory CTL in
lymphatic tissues when latency is established after a long
period of persistent viral replication. Such memory CTL can
be restimulated to effector CTL in vitro by adding infectious
MCMV, and mesenteric lymph nodes turned out to be a
superior source of memory CTL specific for IE membrane
antigens (21).
Therefore, mesenteric lymph node lymphocytes derived
from latently infected female BALB/c mice 10 months after
primary infection were used for the cloning of CTL (started
10 July 1984). Lymphocytes (5 x 106) were restimulated in a
2-ml culture with 5 x 105 PFU ofMCMV in the presence of
5 x 106 30-Gy y-ray-irradiated splenocytes which were
derived from latently infected, syngeneic donors to serve as
antigen-presenting cells. The number of restimulations with
antigen was recorded in the form of a code beginning with Al
to document the stage of the clones in later experiments. For
cloning and long-term propagation ofCTL, minimal essential
medium alpha without nucleosides (catalog number
320-2561; GIBCO Laboratories) was used supplemented
with 10% fetal calf serum, 4 mM L-glutamine, 5 x 10-5 M
2-mercaptoethanol, 10mM HEPES (N-2-hydroxyethylpiper-
azine-N'-2-ethanesulfonic acid) buffer (pH 7.2), 100 U of
penicillin per ml, 0.1 mg of streptomycin sulfate per ml, 0.1
mg of kanamycin per ml, 2.5 ,ug of amphotericin B per ml,
and occasionally, 1 ,ug of tylosin tartrate per ml. With the
exception of the first restimulation, 50 U of interleukin-2
(IL-2; lymphokine supernatant of concanavalin A-activated
rat splenocytes containing 500 U of IL-2 per ml) was added
per ml. After the second restimulation, CTL were cloned by
plating 0.5 lymphocytes per culture in round-bottomed
0.2-ml microtiter wells at a clone probability (17) of 77%,
calculated under the premise that every cell is able to grow.
The cloning microcultures had to be restimulated three times
by refeeding with virus, antigen-presenting cells, and IL-2
until growing clones became visible (stage A5). The fre-
quency of growing cells was then found to be 10-2, and thus,
the apparent clone probability was found to be >99%.
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FIG. 1. Specific recognition of an IE membrane antigen and a virion S antigen by CTL clones. At stage A17, the specificity of cloned CTL
lines was tested in a cytolytic assay. Selective synthesis of IE proteins in target IE MEF was achieved by infection of tertiary MEF
(multiplicity of 2 PFU per cell) in the presence of cycloheximide (50 ,ug/ml) that was replaced after 3 h by actinomycin D (5 jig/ml). S MEF
were prepared by mock infection with UV light (18,000 J/m2 at 254 nm)-inactivated virus (S input with 2 and S high with 200 PFU equivalents
per cell). For each of the indicated effector-to-target-cell ratios (1,000 51Cr-labeled target cells), specific lysis was determined in six replicates
in a standard 3-h 51Cr release assay. Mean values are normalized to the maximum specific lysis (33% for line IE1-A and 37% for line Si-A)
observed in the presence of concanavalin A (ConA) (20 p.g/ml) at the highest effector-to-target-cell ratio tested.
Clones were transferred for expansion first to 48-well (1-ml)
and finally to 24-well (2-ml) culture plates. Further propaga-
tion of the lines, designated A-lines (18) to indicate
restimulation by antigen, was routinely done for >6 months
by a twofold split of cultures every 6 days and restimulation
of the subcultures.
The specificity of two cytolytic lines established that way,
IEl-A and Si-A, was analyzed at stage A17 of in vitro
propagation (Fig. 1). Tertiary MEF target cells exhibited
either IE or S antigens. IE MEF expressed IE membrane
antigens after enhanced, selective de novo synthesis of IE
proteins, accomplished by infection in the consecutive pres-
ence of cycloheximide and actinomycin D (for the rationale
of this procedure, see references 8, 21, and 22). The IE
proteins expressed in these target cells were characterized
by immunoprecipitation (12). S MEF carried only viral S
antigens integrated into the target cell membrane from
without by mock infection with UV light-inactivated, puri-
fied virions or by infection in the presence of actinomycin D
(21, 22). Lectin (e.g., concanavalin A)-mediated lysis allows
measuring the lytic potential of a test population regardless
of the expression of relevant antigens on the target cells (22)
and was used to define the maximum specific lysis (4).
With line IEl-A, the maximum cytolytic effect was ob-
served when IE MEF were used as indicator cells. Lysis was
not detectable when MEF were mock infected with the same
dose of inactivated virus (S input) and was still completely
negative even when the dose was increased by 100-fold (S
high). On the other hand, line Si-A lysed target S high MEF
to the maximum possible degree. On target IE MEF and on
the control target S input MEF, line Si-A detected the same
low amount of a virion S antigen (now defined as the Si
antigen) that was integrated into the target cell membrane
during penetration of the virions. The de novo synthesis of
IE proteins in IE MEF did not contribute to cytolysis by line
Si-A. With neither of the CTL lines could lysis be observed
when inhibitor-treated, noninfected MEF were used as tar-
get cells (data not shown).
Thus, the cloned lines IEl-A and Si-A recognize their
respective antigens in a mutually exclusive way. This result
proves that the IE membrane antigen detected by clone IEl
is not among the structural antigens of the virion that
become integrated into the target cell membrane during the
process of penetration.
Lyt-2- natural killer cells are also involved in immunity to
MCMV infection and can be maintained as lines growing in
IL-2 (1). It was therefore indispensable to verify that both
clones belong to the lineage of self-restricted CTL to sustain
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FIG. 2. Flow cytometric analysis of the surface phenotype of CTL clones. At stage A21, cells of the cloned lines were separated from dead
feeder cells by Lymphoprep (Nyegaard, Oslo, Norway) density gradient centrifugation. The sandwich technique was applied for specific
staining. For the first antibody, monoclonal antibody (mAB) anti-Lyt-2.2 (immunoglobulin G2a [IgG2a]) produced by hybridoma 19/178 (7),
mAB anti-Lyt-1.2 (IgM) produced by hybridoma C3PO (16), or mAB GK1.5 (IgG2b) specific for the L3T4a determinant (4) was used. For the
second antibody, fluorescein-conjugated affinity-purified F(ab')2 fragments of goat anti-rat IgG (for mAB GK1.5) or goat anti-mouse IgG
(Jackson Immuno Research, Avondale, Pa.) was used. Flow cytometric analysis was carried out on a fluorescence-activated cell sorter (FACS
IV; Becton Dickinson FACS Systems, Sunnyvale, Calif.). The fluorescence signal was triggered on particles of size greater than platelets, and
propidium iodide (2 FLg/ml)-stained dead cells were excluded by electronic gating. Results are expressed on a log fluorescence scale with 104
cells analyzed. The control profiles obtained by staining with second antibody alone are shown superimposed with finer contours only on the
positive fluorescence histograms obtained with mAB anti-Lyt-2.2.
the conclusion that the CTL response discriminates between
antigens associated with different phases of the viral replica-
tive cycle.
Analysis of lymphocyte surface marker expression by flow
microfluorometry, with syngeneic thymocytes as a positive
reference to allow comparison of antigen densities (left
vertical panel of fluorescence histograms in Fig. 2), revealed
that both clones, Si-A as well as IE1-A at stage A21 (about
4 months) of in vitro propagation, expressed the Lyt-2.2
antigen (upper horizontal panel of fluorescence histograms in
Fig. 2), whereas the Lyt-1.2 antigen and the L3T4 (MT4)
antigen (4) were not detectable. In conclusion, both cytolytic
clones belong to the Lyt-2+, Lyt-1-, L3T4- subset of T
lymphocytes.
To determine whether the CTL lines recognize their
respective MCMV-specified antigens in association with
TABLE 1. Class I MHC antigen restriction of cloned MCMV-specific CTL lines"
Target cells (% specific lysis at E/T ratios of 5:1 and 1.25:1) from line:
Effector cells Protocol KD2SV B6/WT-3 KHTGSV K5RSV
code (K"DL") (K/7DLh) (K"DLO) (KbDLd)
IE/S/ni IE/S/ni IE/S/ni IE/S/ni
Clone Si-A A31 -/67-35/2-1 -/2-1/0-2 -/0-0/1-0 -/27-12/0-1
Clone S2-A A27 -/33-22/12-0 -/2-2/2-0 -/4-1/1-0 -/38-25/12-3
Clone S3-A A31 -/36-25/0-0 -/1-1/0-0 -/0-0/0-0 -/0-1/0-0
Clone IE1-A A31 58-30/4-1/0-0 2-0/0-0/0-0 0-0/0-2/0-0 31-15/2-0/0-0
Clone lEl-IL A22IL9 65-29/0-0/0-0 0-0/1-0/1-0 4-0/0-0/0-0 18-4/0-0/0-0
Polyclonal H-2b anti-H-2d/A2 -/1 /57-41 -1-16-4 -/-149-31 /1 /31-19
Polyclonal H-2d anti-H-2*bA2 -1-17-2 -/-/49-24 -/-/29-17 -/33-12
" Simian virus 40-transformed cell lines were derived from C57BL/6 MEF (19) (line B6/WT-3) or from kidney tissue of congenic B10 strains (14) B10.D2 (line
KD2SV), B10.HTG (line KHTGSV), and B10.A(5R) (line K5RSV). The lines were used as target cells after either MCMV infection (multiplicity of 20 PFU per
cell) under conditions of selective IE gene expression (IE) or integration of high amounts (200 PFU equivalents per cell) of MCMV S proteins (S), or noninfected
(ni) cells were used. Note that S antigens also became integrated into IE target cells and could be detected by S-specific CTL (see Fig. 1). For the sake of clarity,
these data are not included. As in Fig. 1, lytic activity was determined in six replicates for various effector-to-target-cell (E/T) ratios. Representatively, the mean
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class I glycoproteins encoded by genes of the K or DL loci of
the murine major histocompatibility complex (MHC) (13,
27), simian virus 40-transformed cell lines (14) derived from
the congenic recombinant strains B10.HTG (line KHTGSV,
allele combination KdDLb) and B1O.A(SR) (line K5RSV,
allele combination KbDLd) served as target cells after inte-
gration of MCMV S proteins or expression of MCMV IE
membrane antigens. The expression of class I antigens by
the indicator cell lines was controlled with alloantigen-
specificCTL populations (Table 1).
Antigen recognition by the CTL lines Si-A and TEl-A
proved to be DLd restricted, and noninfected indicator cells
were not lysed. This observation implied that these two
MCMV-antigen-specific CTL lines did not recognize minor
histocompatibility antigens of the B10 strains or any of the
antigenic sites (2) of the simian virus 40-specified tumor-
specific transplantation antigen that is expressed in the
transformed cell lines used and can be detected by CTL (2,
5, 14).
Another DLd-restricted CTL line with specificity for
MCMV S antigen, line S2-A (Lyt-2+, Lyt-1-, L3T4-),
showed at least some DLd-associated activity against nonin-
fected target cells, and for line S3-A (Lyt-2+, Lyt-1-,
L3T4-), restriction could not be mapped to an MHC class I
locus.
At restimulation stage A18, lymphokine supernatant as a
source of IL-2 was replaced by recombinant human IL-2 (lot
89050/84802; >99% pure IL-2; specific activity, 7.3 x 106 U
per mg of protein; Sandoz Research Institute, Vienna,
Austria). After stage A22, line TEl-A was split, and a subline
was further propagated as line TEl-IL by passaging in 6-day
intervals in 50 U of recombinant human IL-2 per ml without
antigen or feeder cells. At stage A22IL9, line IEl-IL was
found to be strictly IL-2 dependent (data not shown) and to
have retained lytic activity, antigen specificity, and MHC
restriction (Table 1). Meanwhile (20 July 1985), several
stable subclones of line IEl-IL have been established by
repeated recloning and could be maintained for >7 months
by continuously growing in recombinant human IL-2.
In conclusion, we report the selection of a monoclonal
IL-2-dependent CTL line specific for an IE membrane anti-
gen expressed by cells as a result of selective synthesis of
MCMV IE proteins. Since T lymphocytes possess a receptor
with idiotypic specificity (10), clone TEl can be used to
define the antigenic determinant TEl of an IE membrane
antigen. The predominant IE protein is a nonglycosylated
phosphoprotein (pp89) and is located in the nucleus and
cytoplasm of the infected cell (12). The finding that lysis by
clone TEl could not be inhibited with either polyspecific
murine antiserum or IE pp89-specific monoclonal antibody
MCMV-6/20/1 (M. J. Reddehase and M. R. Fibi, unpub-
lished observations) is in line with the apparent intracellular
localization of pp89 but cannot be considered a formal proof
against surface localization of a minor fraction of native or
modified pp89. Recognition of fibroblasts by CTL was also
observed after gene transfer of an influenza A virus gene
coding for the nucleoprotein which is a nonglycoprotein
component of the virion (24). Although MCMV IE proteins
are not components of the virion, the analogy between
influenza A virus infection and MCMV infection, with re-
spect to the involvement of intracellular nonglycoproteins in
recognition of infected cells by CTL, points to a more
general phenomenon concerning antigen presentation by
virus-infected cells. Since fibroblasts are capable of antigen
processing and can present peptide fragments of proteins to
T cells, provided that the relevant MHC gene products are
expressed (15), processing products of IE proteins also could
serve as antigens presented iri association with the MHC-
encoded class I glycoproteins. The line TEl-IL provides the
basis for studying the expression of the epitope TEl after
transfection of cells with authentic or mutated IE genes and
will aid molecular genetic and biochemical analysis in de-
fining the nature of the lymphocyte-detected IE antigen.
A therapeutic effect of CTL on established MCMV pneu-
monia has already been demonstrated with a polyclonal
population (23). A possible implication of IE membrane
antigens in the immune control of viral replication in tissues
of an infected host can now be evaluated with monoclonal
probes.
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